Episode Details

Back to Episodes

TTP #94: Dr. Michelle Friedman-Yakoobian – Early Identification of Psychosis

Published 6 years, 10 months ago
Description

How many of us have been in a clinical interview and wondered, “Could this be a thought disorder?” Sometimes it’s unclear which symptoms are worth concern and which ones are more typical. My guest today, Dr. Michelle Friedman-Yakoobian, has been conducting research and practice with psychotic disorders and prodromal states for nearly her entire academic career. We cover a lot of ground during this interview. Here are just a few things that we discuss:

  • When should we really start assessing for psychosis?
  • How to separate OCD from delusions or hallucinations?
  • The CEDAR Clinic’s standard battery for assessing psychotic symptoms
  • Treatment recommendations for high-risk individuals

Cool Things Mentioned


The Testing Psychologist podcast is now approved for CEU’s!

I’m excited to announce that I’ve partnered with At Health to offer CE credits for podcast episodes! Visit this link to access current and past episodes available for CE credit. You can use code “TTP10” for a discount on ALL the course credits you purchase from At Health!

About Dr. Michelle Friedman-Yakoobian


Michelle Friedman-Yakoobian, Ph.D. is a licensed clinical psychologist and is the Clinical Team Leader for the CEDAR Clinic. Dr. Friedman-Yakoobian supervises trainees in the clinic, and meets with young adults and families for consultations, educational groups, and cognitive behavioral therapy. In addition, Dr. Friedman-Yakoobian presents at schools and other community youth agencies to raise awareness about new advances in early detection and treatment of early signs of psychosis. Dr. Friedman-Yakoobian also does the Director of Psychology Training in the Prevention and Recovery in Early Psychosis Program (PREP), another early psychosis program housed at The Spot.

About Dr. Jeremy Sharp

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us